Shares of Vitalhub Corp. (TSE:VHI - Get Free Report) dropped 0.4% on Wednesday . The company traded as low as C$10.04 and last traded at C$10.09. Approximately 81,083 shares traded hands during trading, a decline of 37% from the average daily volume of 128,883 shares. The stock had previously closed at C$10.13.
Analyst Ratings Changes
Several brokerages recently issued reports on VHI. TD Securities increased their price objective on Vitalhub from C$13.00 to C$14.00 and gave the stock a "buy" rating in a research note on Monday, March 31st. Raymond James set a C$13.50 target price on shares of Vitalhub and gave the stock an "outperform" rating in a research report on Thursday, March 27th. Four equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has an average rating of "Buy" and an average target price of C$12.90.
View Our Latest Stock Report on VHI
Vitalhub Trading Up 3.2%
The firm has a market capitalization of C$573.38 million, a price-to-earnings ratio of 172.41, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. The company has a fifty day moving average price of C$10.30 and a 200-day moving average price of C$10.62.
Insider Activity at Vitalhub
In other Vitalhub news, Director Francis Nelson Shen bought 25,000 shares of the stock in a transaction on Friday, May 16th. The shares were purchased at an average cost of C$10.23 per share, with a total value of C$255,750.00. Insiders own 18.57% of the company's stock.
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
See Also
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.